Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (19 ops.)
Latest filing published 31 Aug 2026 for CYTOKINETICS INC, €201k. Read the official filing
Filing timeline
BuySaleAndrew Callos
Insider track record
Disclosed buys
0
Disclosed sells
19
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Andrew Callos: trading record in brief
All filings by Andrew Callos on record concern Cytokinetics Inc, in the capacity of senior executive. We count 44 filings; the first trade dates from 16 February 2022 and the latest from 31 August 2026.
No open-market purchase appears, only 19 sales worth €6.6M. Other entries cover 12 share grants and 13 option exercises. 2026 to date brings no purchases and 11 sales.
Most recently, on 31 August 2026, the filings show an option exercise worth €201k in Cytokinetics Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Andrew Callos
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations44 total
10,000 shares@ US$23.260.0023% mcap2.7% of flowCommon StockSEC:0001061983-26-000090:0
10,000 shares@ US$70.240.0070% mcap8.3% of flowCommon StockSEC:0001061983-26-000090:1
14,000 shares@ US$23.260.0030% mcap4.4% of flowCommon StockSEC:0001061983-26-000086:0
14,000 shares@ US$79.880.010% mcap14.9% of flowCommon StockSEC:0001061983-26-000086:1
15,000 shares@ US$23.260.0038% mcap8.4% of flowCommon StockSEC:0001061983-26-000065:0
15,000 shares@ US$74.080.012% mcap26.9% of flowCommon StockSEC:0001061983-26-000065:1
15,000 shares@ US$23.260.0029% mcap26.9% of flowCommon StockSEC:0001061983-26-000045:0
15,000 shares@ US$63.260.0080% mcap73.1% of flowCommon StockSEC:0001061983-26-000045:1
7,449 shares@ US$66.020.0041% mcap27.3% of flowCommon StockSEC:0001061983-26-000036:0
3,639 shares@ US$65.0010.4% of flowCommon StockSEC:0001061983-26-000030:0
1,930 shares@ US$62.074.4% of flowCommon StockSEC:0001061983-26-000025:0
5,626 shares@ US$62.1512.8% of flowCommon StockSEC:0001061983-26-000028:0
20,646 shares0Common StockSEC:0001061983-26-000023:0
1,709 shares@ US$61.033.7% of flowCommon StockSEC:0001061983-26-000019:0
2,582 shares@ US$60.722.6% of flowCommon StockSEC:0001061983-26-000018:0
11,000 shares@ US$39.137.0% of flowCommon StockSEC:0001061983-26-000015:0
886 shares@ US$37.630.5% of flowCommon StockSEC:0001061983-26-000013:0
15,000 shares@ US$23.265.6% of flowCommon StockSEC:0001061983-26-000012:0
886 shares@ US$37.630.5% of flowCommon StockSEC:0001061983-26-000011:0
15,000 shares@ US$23.265.7% of flowCommon StockSEC:0001061983-26-000002:0
913 shares@ US$62.090.9% of flowCommon StockSEC:0001061983-26-000001:0
1,809 shares@ US$62.442.4% of flowCommon StockSEC:0001061983-25-000057:0
1,589 shares0Common StockSEC:0001061983-25-000054:0
1,042 shares@ US$39.130.9% of flowCommon StockSEC:0001061983-25-000049:0
15,000 shares@ US$23.267.6% of flowCommon StockSEC:0001061983-25-000048:0
25 of 44 declarations
